A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

This study is currently recruiting participants.

Verified January 2013 by AesRx, LLC

Sponsor:

Collaborators:

Cato Research

ClinPharm Consulting, LLC

Infrared Imaging and Thermometry Unit, Biomedical Engineering and Physical Science Shared Resource (NIBIB)

National Chung Cheng University

QS Pharma

Ricerca Biosciences LLC

SAIC-Frederick, Inc.

Information provided by (Responsible Party):

AesRx, LLC

ClinicalTrials.gov Identifier:

NCT01597401

First received: April 26, 2012

Last updated: January 17, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	May 2013
Estimated Primary Completion Date:	May 2013 (Final data collection date for primary outcome measure)